The Lancet · 2008 · 966 citations · 45 references
MedicineCardiologyPharmacologyClinical PharmacologyPharmacogeneticsPharmacogenomicsCardiovascular DiseaseCardiovascular PharmacologyCytochrome P450 EnzymesCytochrome P450-mediated MetabolismIschemic Heart DiseasePharmacogenomics In CardiologyCohort Study InvestigationCyp2c19 Drug MetabolismCyp2c19 GenotypeCyp2c19 PharmacogeneticsCyp2c19-guided Antiplatelet TherapyCytochrome P450 2C19 GenotypingCytochrome P450 Genetic PolymorphismMyocardial Infarction Pharmacogenomics
45
Markers of Inflammation and Cardiovascular Disease
Thomas A. Pearson, George A. Mensah, R. Wayne Alexander et al. · Circulation · 2003 · 6.4K citations · Full text
Clinical End Points in Coronary Stent Trials
Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
Steven R. Steinhubl, Peter B. Berger, J. Tift Mann et al. · JAMA · 2002 · 3.1K citations